Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 4, 2006

University of Oklahoma Deploys Ariadne Pathway Studio

  • The University of Oklahoma Health Sciences Center will useAriadne Genomics’ Pathway Studio software solution to develop a comprehensive collection of cancer-related pathways. The collection will be made available to Ariadne customers at no charge as an add-on to the pathway analysis product line.

    “We will perform scientific evaluation of pathway expansion and microarray data analysis algorithms available in Pathway Studio,” explains Dee Wu, an associate professor at the OU Health Sciences Center. “Then we will build up a collection of cancer-related pathways using its built-in ResNet database and advanced pathway reconstruction and literature mining tools.”

    Pathway Studio enables life scientists to identify relationships among proteins, small molecules, cell processes, and treatments and to automatically extract relevant biological interactions from scientific literature.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »